For Immediate Release
Louisville, Kentucky January 13, 2022.
Butchertown Clinical Trials, an outpatient clinical trials site, today announced the promotion of Kellye Johnson to Clinical Trials Site Director. She will have the overall responsibility for site workflow and resources management.
Kellye has been integral to our development during the past five years, and we are thrilled to promote her to this newly created position, said Mark Prussian, CEO of Butchertown Clinical Trials.
Ms. Johnson joined the organization in 2016 as a Clinical Research Associate before the clinical trials group began operating under the name Butchertown Clinical Trials, a division of The Eye Care Institute.
Ms. Johnson earned a Bachelor of Arts in Biology from Indiana University Southeast. She is a member of the Association of Clinical Research Professionals, a trade industry group.
Butchertown Clinical Trials is an ambulatory clinical trial site in the Butchertown neighborhood of Louisville, KY. The company provides ophthalmology, optometry, family practice, vaccine, endocrine, and nutrition clinical trials. With 15 FDA approved drugs or devices, having completed over 350 trials, and currently enrolling for 21 trials, management believes Butchertown Clinical Trials is the largest and most successful privately owned ophthalmic clinical trials site in the US.
# # #
For more information contact Mark Prussian @mprussian@eyecareinstitute.com
